Published in Br J Clin Pharmacol on October 01, 1992
Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Dig Dis Sci (2007) 0.83
Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol (2006) 0.83
Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors. Virchows Arch (2009) 0.76
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The distribution and properties of a histamine-methylating enzyme. J Biol Chem (1959) 2.52
The specificity of S-adenosylmethionine derivatives in methyl transfer reactions. J Biol Chem (1969) 1.71
The metabolism of ring-labeled histamine. J Biol Chem (1952) 1.30
Brain histamine N-methyltransferase purification, mechanism of action, and inhibition by drugs. Biochem Pharmacol (1978) 1.09
New inhibitors of histamine-N-methyltransferase. Biochem Pharmacol (1979) 1.02
Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants. Biochem Pharmacol (1990) 0.95
The kinetic properties and reaction mechanism of histamine methyltransferase from human skin. Biochem J (1980) 0.93
Optimization of histamine radio enzyme assay with purified histamine-N-methyltransferase. Clin Chim Acta (1988) 0.90
Human brain sulphotransferase and glucuronyltransferase. Hum Exp Toxicol (1990) 0.89
The oxidation of histamine to imidazoleacetic acid in vivo. J Biol Chem (1952) 0.87
Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase. Biochem Pharmacol (1978) 0.87
Structural features of potent inhibitors of rat kidney histamine N-methyltransferase. Biochem Pharmacol (1988) 0.86
Thiol methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther (1991) 0.84
Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: fact or fictions? Agents Actions (1984) 0.84
Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Biochem Pharmacol (1990) 0.84
Structural requirements of imidazole compounds to be inhibitors or activators of histamine methyltransferase: investigation of histamine analogues and H2-receptor antagonists. Agents Actions (1978) 0.83
Thiopurine methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther (1991) 0.83
Human erythrocyte histamine N-methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta (1985) 0.82
Effect of amodiaquine on gastric histamine methyltransferase and on histamine-stimulated gastric secretion. Br J Pharmacol (1975) 0.81
Effects of drugs on the activity of histamine-N-methyltransferase from guinea pig skin. Biochem Pharmacol (1988) 0.80
Inhibitors of histamine metabolism in vitro and in vivo. Correlations with antitrypanosomal activity. Biochem Pharmacol (1984) 0.79
Stereochemical course of the transmethylation catalyzed by histamine N-methyltransferase. Arch Biochem Biophys (1984) 0.78
Methylation of captopril in human liver, kidney and intestine. Xenobiotica (1991) 0.78
Regulation of the activity of histamine-N-methyltransferase from guinea pig skin by biogenic amines. Exp Mol Pathol (1986) 0.78
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques. Nat Med (2000) 2.33
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol (2003) 1.20
Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. J Immunol (2001) 1.19
S-methyltransferases in human intestine: differential distribution of the microsomal thiol methyltransferase and cytosolic thiopurine methyltransferase along the human bowel. Xenobiotica (1993) 0.97
Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol (1998) 0.96
A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. Cancer (1989) 0.96
Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver. Br J Clin Pharmacol (1991) 0.94
Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer (1991) 0.94
Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis? Int J Cancer (2001) 0.93
[Renal cancer embolization with isobutyl-2-cyanoacrylate. Experimental study and first clinical applications (author's transl)]. J Radiol Electrol Med Nucl (1977) 0.92
Experience with hair testing in the clinical biochemistry laboratory of Ca' Granda Niguarda Hospital, Milan, Italy. Forensic Sci Int (1997) 0.90
Structural changes induced in proteins by therapeutic ultrasounds. Ultrasonics (2009) 0.90
Conjugation pathways in liver disease. Br J Clin Pharmacol (1990) 0.88
Dynamics of the ion cyclotron resonance effect on amino acids adsorbed at the interfaces. Bioelectromagnetics (2006) 0.88
Glutathione S-transferase in humans: development and tissue distribution. Arch Toxicol (1988) 0.88
Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin Cancer Res (2001) 0.87
Development of the glucuronyltransferase and sulphotransferase towards 2-naphthol in human fetus. Dev Pharmacol Ther (1989) 0.87
Sulfotransferase in humans: development and tissue distribution. Pharmacology (1988) 0.87
Cytosolic epoxide hydrolase in humans: development and tissue distribution. Arch Toxicol (1988) 0.87
Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. J Urol (1991) 0.86
Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol (1983) 0.85
Distribution of 2-naphthol sulphotransferase and its endogenous substrate adenosine 3'-phosphate 5'-phosphosulphate in human tissues. Eur J Clin Pharmacol (1989) 0.85
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group. Eur J Cancer (1993) 0.85
Prevalence and patterns of antibiotic prescribing in Italian hospitals. Infection (2003) 0.84
Lymphadenectomy and renal cell carcinoma: why is there so much controversy? Eur Urol (1983) 0.84
Thiol methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther (1991) 0.84
Hormonal pattern and testicular histology in patients with prostatic cancer after long-term treatment with a gonadotropin-releasing hormone agonist analogue. Eur Urol (1988) 0.83
50 Hz extremely low frequency electromagnetic fields enhance protein carbonyl groups content in cancer cells: effects on proteasomal systems. J Biomed Biotechnol (2009) 0.83
A rapid, simple, and inexpensive step facilitates RNA extraction from whole blood cells. Lab Invest (1999) 0.83
Transcatheter embilization of the hypogastric arteries in cases of bladder hemorrhage from advanced pelvic cancers: followup in 9 cases. J Urol (1980) 0.83
Thiopurine methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther (1991) 0.83
Erythropoietin expression in primary rat Sertoli and peritubular myoid cells. Blood (2001) 0.83
Hydroxyurea in the management of chronic urea-splitting urinary infections. Br J Urol (1980) 0.82
SNOM and AFM microscopy techniques to study the effect of non-ionizing radiation on the morphological and biochemical properties of human keratinocytes cell line (HaCaT). J Microsc (2004) 0.82
Bethanechol versus antiacids in the treatment of gastroesophageal reflux. Helv Paediatr Acta (1985) 0.82
Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Dev Pharmacol Ther (1991) 0.82
Exposure to 50 Hz electromagnetic radiation promote early maturation and differentiation in newborn rat cerebellar granule neurons. J Cell Physiol (2005) 0.82
Sulphation and glucuronidation of ritodrine in human foetal and adult tissues. Eur J Clin Pharmacol (1993) 0.82
Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa. Pharmacology (1990) 0.82
Clastogenicity and aneuploidy in newborn and adult mice exposed to 50 Hz magnetic fields. Int J Radiat Biol (2006) 0.81
Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: correlation with local relapses. Int J Oncol (1999) 0.81
Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res (2001) 0.80
On chromosomal instability: what is the karyotype of your 32D CI3 cell line. Blood (2000) 0.80
Diagnostic value and learning curve of transbronchial needle aspiration in thoracic surgery. Minerva Chir (2006) 0.80
Exposure to 900 MHz electromagnetic field induces an unbalance between pro-apoptotic and pro-survival signals in T-lymphoblastoid leukemia CCRF-CEM cells. J Cell Physiol (2004) 0.80
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. Cancer Detect Prev (1991) 0.79
Follicle-stimulating hormone, testosterone, and hypoxia differentially regulate UDP-glucuronosyltransferase 1 isoforms expression in rat sertoli and peritubular myoid cells. J Steroid Biochem Mol Biol (2000) 0.79
Gelatin foam and isobutyl-2-cyanoacrylate in the treatment of life-threatening bladder haemorrhage by selective transcatheter embolisation of the internal iliac arteries. Br J Urol (1979) 0.79
Usefulness of preoperative transcatheter embolization in kidney tumors. Urology (1981) 0.79
Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression. Oncol Rep (1998) 0.78
Three dimensional (3D) analysis of the morphological changes induced by 50 Hz magnetic field exposure on human lymphoblastoid cells (Raji). Bioelectromagnetics (2000) 0.78
Radiofrequency exposure near high-voltage lines. Environ Health Perspect (1997) 0.78
Zidovudine glucuronidation in human liver: interindividual variability. Int J Clin Pharmacol Ther (1996) 0.78
Methylation of captopril in human liver, kidney and intestine. Xenobiotica (1991) 0.78
Nuclear epoxide hydrolase in the human fetal and adult liver. Pharmacology (1984) 0.78
[Treatment of bladder hemorrhages due to inoperable pelvic cancers by embolization of the hypogastric arteries (author's transl)]. J Radiol (1980) 0.78
Glucuronidation of 1-naphthol in nuclear and microsomal fractions of the human intestine. Pharmacology (1986) 0.78
Phase II study of navelbine in advanced renal cell carcinoma. Eur J Cancer (1991) 0.78
Human liver sulphotransferase and UDP-glucuronosyltransferase: structure-activity relationship for phenolic substrates. Xenobiotica (1991) 0.77
Interindividual variability of the human hepatic sulphotransferases. Chem Biol Interact (1994) 0.77
Glutathione conjugation with 1-chloro-2,4-dinitrobenzene (CDNB): interindividual variability in human liver, lung, kidney and intestine. Int J Clin Pharmacol Ther (1995) 0.77
Ritodrine sulphation in the human liver and duodenal mucosa: interindividual variability. Eur J Drug Metab Pharmacokinet (1998) 0.77
Identification and characterization of a novel expandable adult stem/progenitor cell population in the human exocrine pancreas. J Endocrinol Invest (2008) 0.77
Characterization of sulphotransferase in human ileum and colon. Pharmacology (1989) 0.77
Cytosolic epoxide hydrolase in fetal and adult human liver. Arch Toxicol (1983) 0.77
(+) and (-) terbutaline are sulphated at a higher rate in human intestine than in liver. Eur J Clin Pharmacol (1993) 0.77
Interindividual variability in the N-sulphation of desipramine in human liver and platelets. Br J Clin Pharmacol (1992) 0.77
Painless extracorporeal shock wave lithotripsy for outpatients: a new option. Eur Urol (1989) 0.77
[Testis autotransplantation in the abdominal cryptorchidism (author's transl)]. J Urol (Paris) (1981) 0.77
Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5'-diphosphoglucuronic acid in human tissues. Eur J Clin Pharmacol (1991) 0.76
Conjugation of benzoic acid with glycine in the human fetal and adult liver and kidney. Dev Pharmacol Ther (1991) 0.76
Uridine 5'-diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta. Eur J Drug Metab Pharmacokinet (2001) 0.76
The role of venography and sclerotherapy in the management of varicocele. Eur Urol (1984) 0.76
Profile of drug-metabolizing enzymes in human ileum and colon. Pharmacology (1989) 0.76
Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer. Ann N Y Acad Sci (1993) 0.76
Parathyroid autotransplantation. Eur Urol (1981) 0.75
Flexible antegrade and retrograde nephroscopy: review of 50 cases. Eur Urol (1990) 0.75
Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP). Eur Urol (1990) 0.75
[Diagnostic and therapeutic problems of renal hydatidosis]. Gazz Sanit (1965) 0.75
[Extracorporeal lithotripsy using the Lithoring multi-one, a third generation lithotripter]. Arch Ital Urol Nefrol Androl (1990) 0.75
Minoxidil sulphation in human liver and platelets. A study of interindividual variability. Eur J Clin Pharmacol (1993) 0.75
Propionhydroxamic acid in the management of struvite urinary stones. Contrib Nephrol (1987) 0.75
Percutaneous debulking of staghorn stones combined with extracorporeal shockwave lithotripsy: results and complications. Eur Urol (1988) 0.75
First experience with the Lithoring in the management of urinary stones. Eur Urol (1990) 0.75
Neoadjuvant or definitive alternating chemotherapy and radiotherapy for infiltrating bladder cancer. Am J Clin Oncol (1989) 0.75
Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase. Arch Toxicol (1989) 0.75
Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer. Cancer Chemother Pharmacol (1988) 0.75
[Antibiotic prevention with aztreonam in urologic surgery in children]. Minerva Urol Nefrol (1989) 0.75
[Basedow's disease and atypical ophthalmologic signs]. Bull Soc Ophtalmol Fr (1991) 0.75
[Monodose aztreonam in the prevention of infection after extracorporeal shockwave lithotripsy. Theoretical premises]. Minerva Urol Nefrol (1989) 0.75
In situ or retrograde manipulation of ureteral stones: still a controversy? Arch Esp Urol (1989) 0.75
Non-invasive treatment of renal and ureteral lithiasis: relationship with the site and nature of the stone. Contrib Nephrol (1987) 0.75
Diagnosis of male impotence after intracavernous papaverine test. Eur Urol (1988) 0.75
[The vas deferens as a model for the study of psychotropic drugs]. Clin Ter (1987) 0.75
Penile-brachial pressure index as a guide for the dosage of intracavernous injection of papaverine. Eur Urol (1988) 0.75